"Peacemaker" immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune ...

A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, researchers at Stanford Medicine have found. Manipulating this pathway ...

The Nobel-prize season always kicks off with the award for physiology or medicine, which highlights work in fields such as genetics, cell biology and evolution. This year’s award went to three ...

Every day, your immune system performs a delicate balancing act, defending you from thousands of pathogens that cause disease while sparing your body's own healthy cells. This careful equilibrium is ...

All 63 donor-recipient pairs enrolled and treated according to protocol across multiple clinical centers Randomized, controlled Phase IIb trial ...

A new Review reveals how aging can push the immune system into a paradoxical state, weaker against threats yet more prone to attacking the body’s own tissues.

Autoimmune diseases arise from aberrant immune responses against self-antigens, leading to chronic inflammation and tissue damage. Management strategies encompass immunosuppressive and ...

Round led by Lumira Ventures and Roche Venture Fund with new investment from SanofiCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ...

Findings from a new study led by scientists at Stanford University School of Medicine and their colleagues elsewhere show that a single signaling pathway controls whether immune cells attack or ...

The programmed cell death protein-1 (PD-1) pathway constitutes a central regulatory axis in maintaining immune tolerance and preventing self-reactivity. Engagement of PD-1 on T lymphocytes by its ...

The immune system has evolved to mount immune responses against foreign pathogens and to remain silent against self-antigens. A balance between immunity and tolerance is required as any disturbance ...